Novartis Bioventures Ltd 13D and 13G filings for Aileron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-04-16 07:28 am Sale | 2020-04-14 | 13D | Aileron Therapeutics, Inc. ALRN | Novartis Bioventures Ltd | 59,995 4.310% | -18,619 (-23.68%) | Filing |
| 2020-04-13 4:01 pm Sale | 2020-04-09 | 13D | Aileron Therapeutics, Inc. ALRN | Novartis Bioventures Ltd | 78,614 5.650% | -15,492 (-16.46%) | Filing |
| 2020-03-18 07:01 am Sale | 2020-03-17 | 13D | Aileron Therapeutics, Inc. ALRN | Novartis Bioventures Ltd | 94,106 6.770% | -9,864 (-9.49%) | Filing |